QuidelOrtho Corp. Stock Hits Day Low of $21.14 Amid Price Pressure

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility in its stock performance. On February 23, 2026, the stock reached an intraday low of USD 21.14, reflecting a notable decline of 10.25% for the day. This drop is part of a broader trend, as the company has reported a 1-day performance of -5.74%, contrasting sharply with the S&P 500's gain of 0.69%. Over the past week, QuidelOrtho's stock has decreased by 10.14%, and its performance over the last month shows a staggering decline of 24.56%. Year-to-date, the stock is down 25.81%, and its one-year performance reveals a significant drop of 47.63%. The company has consistently underperformed against the S&P 500 over the last three years, with a staggering 76.11% decline during this period. Financial metrics indicate challenges, including a pre-tax profit of -USD 50.7 million and a return on equity of -7.95%. The company's debt-to-equity ratio stands at 1.31, further highlighting its financial position. As QuidelOrtho navigates these trends, its stock continues to reflect the pressures faced within the industry.